HBsAg seroprevalence among Senegalese militaries

Military Medical Research

Volumn 2, Issue 1, 2015, Pages

  Ndiaye, Abdoul A ^a,b   Fall, Ibrahima Socé ^b,e   Lo, Gora ^b   Seck, Sidy Mouhamed ^b,c   Tall, Alioune Badara ^a,b   Gueye, Boubacar ^a,b   Mbodj, Amady Barro ^b   Tal Dia, Anta ^d  

^a Alioune Diop University Bambey   (Senegal)

^b Army of Senegal   (Senegal)

^c UNIVERSITÉ GASTON BERGER   (Senegal)

^d UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Chronic diseases; HBsAg; Military; Seroprevalence

Indexed keywords

EID: 84967102595     PISSN: 20957467     EISSN: 20549369     Source Type: Journal    
DOI: 10.1186/s40779-015-0032-7     Document Type: Article

References (30)

1. Lemoine M, Nayagam S, Thursz M. Viral hepatitis in resource-limited countries and access to antiviral therapies. Future Virol. 2013;8:371-80.
2. Jemal A, Bray F, Forman D, O'Brien M, Ferlay J, Center M, et al. Cancer burden in Africa and opportunities for prevention. Cancer. 2012;118:4372-84.
3. Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine. 2008;26:6266-73.
4. Allain JP, Candotti D, Soldan K, Sarkodie F, Phelps B, Giachetti C, et al. The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood. 2003;101(6):2419-25.
5. WHO. Global status report on noncommunicable diseases 2010. Geneva; 2011. Available at: http://whqlibdoc.who.int/publications/2011/9789240686458_eng.pdf (accessed on 25 February 2015).
6. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. 2011;17(2):107-15.
7. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893-917.
8. WHO. Hepatitis B. http://www.who.int/csr/disease/hepatitis/HepatitisB_whocdscsrlyo2002_2.pdf (Accessed 25 February 2015).
9. UN Development Program. http://hdr.undp.org/sites/default/files/hdr14_statisticaltables.xls (Accessed 25 February 2015).
10. International Agency for Research on Cancer. GLOBOCAN factsheet 2008. http://globocan.iarc.fr/ia/World/atlas.html (Accessed 25 February 2015).
11. WHO. Prevention and control of viral hepatitis infection: framework for global action. http://www.who.int/csr/disease/hepatitis/GHP_framework.pdf (Accessed 25 February 2015).
12. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142(6):1264-73.
13. de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13(6):607-15.
14. Lo G, Diawara PS, Diouf NN, Faye B, Seck MC, Sow K, et al. Prévalence de l'antigène de surface du virus de l'hépatite B (AgHBs) chez les femmes enceintes au laboratoire de l'Hôpital Militaire de Ouakam (HMO), Dakar. Med Afr Noire. 2012;5905:241-4.
15. World Health Organization. Instrument STEPS de l'OMS pour la surveillance des facteurs de risque des maladies chroniques(STEPS). http://www.who.int/chp/steps/en/ (Accessed 25 February 2015).
16. Cockcroft DW, Gault MH. Memorial University Research Unit, The General Hospital, St. John's, Newfoundland A1 A 1E5 (Canada). Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41.
17. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis. 2002;39:S1-266.
18. Agence Nationale d'Accréditation et d'Évaluation en Santé. Diagnostic de l'insuffisance rénale chronique chez l'adulte. Recommandations pour la pratique clinique. Paris: ANAES; 2002. p. 124.
19. Kiire CF. The epidemiology and prophylaxis of hepatitis B in sud-saharan Africa: a review from tropical and subtropical Africa. J Gastroenterol Hepatol. 1996;38:S5-12.
20. Uneke CJ, Ogbu O, Inyama PU, Anyanwu GI, Njoku MO, Idoko JH. Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria. Mem Inst Oswaldo Cruz. 2005;100:13-6.
21. Hodges M, Sanders E, Aitken C. Seroprevalence of hepatitis markers: HAV, HBV, HCV, and HBV amongst primary school children in Freetown Sierra Leone. West Afr J Med. 1998;17:36-7.
22. Programme National de lutte contre les hépatites (PNLH). Ministère de la Santé et de l'action sociale, Sénégal. http://www.hepatites.sn/le-pnlh/les-hepatites-au-senegal.html (Accessed 25 February 2015).
23. Lo G, Diouf NN, Sow-Sall A, Ndiaye-Diop H, Diawara PS, Faye B, et al. Prévalence de l'antigène de surface du virus de l'hépatite B au laboratoire de l'hôpital militaire de Ouakam entre 2006 et 2010. Med Afr Noire. 2014;6102:87-93.
24. Conseil National de Lutte contre le Sida, Sénégal, Dakar. Rapport national de surveillance combinée du VIH/sida dans les Armées. 2006;1:1-194
25. Diouf ML, Diouf B, Niang A, Ka EH, Pouye A, Seck A, et al. Prevalence of hepatitis B and C viruses in a chronic hemodialysis center in Dakar. Dakar Med. 2000;45(1):1-4.
26. Huang JF, Chuang WL, Dai CY, Ho CK, Hwang SJ, Chen SC, et al. Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: another chain of link? J Intern Med. 2006;260:255-62.
27. Mocroft A, Neuhaus J, Peters L, Ryom L, Bickel M, Grint D, et al. Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults. PLoS One. 2012;7(7):e40245. doi:10.1371/journal.pone.0040245.
28. Lee JJ, Lin MY, Yang YH, Lu SN, Chen HC, Hwang SJ. Association of hepatitis C and B virus infection with CKD in an endemic area in Taiwan: a cross-sectional study. Am J Kidney Dis. 2010;56:23-31. PubMed Abstract | Publisher Full Text.
29. Lai KN, Li PK, Lui SF, Au TC, Tam JS, Tong KL, et al. Membranous nephropathy related to hepatitis B virus in adults. N Eng J Med. 1991;324:1457-63 [PubMed].
30. George E, Nadkarni GN, Estrella MM, Lucas GM, Sperati CJ, Atta MG, et al. The impact of hepatitis C coinfection on kidney disease related to human immunodeficiency virus (HIV): a biopsy study. Medicine (Baltimore). 2011;90:289-95 [PubMed].